Discover 1,438 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,438
IVIG for Infection Prevention After CAR-T-Cell Therapy
for
Hematologic Malignancies
Location: Seattle WA, Portland OR, Duarte CA, New York NY,
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT05952804
Phase2, Recruiting
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT05098210
Phase1, Recruiting
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
for
Metastatic Malignant Solid Neoplasm,
Location: Seattle WA, Salt Lake City UT, Duarte CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687110
Phase1, Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors, HNSCC, SCLC, NSCLC,
Location: Seattle WA, Rochester MN, Irving TX, St Louis MO,
Sponsor: Tubulis GmbH
Sex: All
Age: 18+
Code: NCT06657222
Phase1, Phase2, Recruiting
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
for
Leukemia, Myeloid, Chronic, Myeloid Leukemia,
Location: Seattle WA, Duarte CA, Houston TX, Cleveland OH,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT04260022
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
for
Prostate Cancer
Location: Seattle WA, Vancouver, Sacramento CA, Houston TX,
Sponsor: University of British Columbia
Sex: Male
Age: 18+
Code: NCT04812366
Phase2, Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Seattle WA, Portland OR, Calgary, San Francisco CA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase2, Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Seattle WA, Portland OR, Duarte CA, Los Angeles CA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase1, Phase2, Recruiting
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Location: Seattle WA, Edmonton, Sacramento CA, Palo Alto CA,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05118789
Phase1, Phase2, Recruiting
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
for
B-All, Acute Lymphoblastic Leukemia
Location: Seattle WA, Salt Lake City UT, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 25
Code: NCT05621291
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Location: Seattle WA, Salt Lake City UT, Los Angeles CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06445062
Phase1, Phase2, Recruiting
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
MYELODYSPLASTIC SYNDROME; MDS, ACUTE MYELOID LEUKEMIA; AML
Location: Seattle WA, Portland OR, Stanford CA, Salt Lake City UT,
Sponsor: Jasper Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04429191
Phase1, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Seattle WA, Vancouver, San Francisco CA, Glendale CA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase3, Recruiting
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms